Jakarta, INTI – Amid the rising cases of drug-resistant bacterial infections worldwide, researchers from the Massachusetts Institute of Technology (MIT) have achieved a medical breakthrough. With the help of artificial intelligence (AI), they successfully discovered two new antibiotic candidates capable of killing dangerous bacteria such as MRSA (Methicillin-resistant Staphylococcus aureus) and drug-resistant gonorrhea. This discovery is seen as the potential start of a “second golden age” in antibiotic development after a long period of stagnation.
Drugs Designed Atom by Atom by AI
These two new antibiotics were designed atom by atom using generative AI. The system analyzed millions of chemical compounds, including previously unknown ones, to predict which molecules could effectively combat bacteria. AI learned how molecular structures composed of carbon, oxygen, hydrogen, and nitrogen affect bacterial growth while ensuring the resulting drugs are safe for humans and distinct from existing antibiotics.
Fast and Efficient Compared to Traditional Methods
Unlike conventional drug discovery methods that can take years, MIT’s AI can screen millions of compounds in just a few days. Two design methods were used: one started from small chemical fragments, while the other gave AI complete freedom from the beginning. Selected molecules were then tested in laboratories and on animals, resulting in two promising antibiotic candidates effective against resistant bacteria.
Promising Laboratory Results
Early results indicate that bacteria struggle to develop resistance to these new antibiotics quickly. Tests on infected mice also showed positive outcomes. According to Prof. James Collins from MIT, AI allows rapid and cost-effective generation of new molecules, expanding humanity’s arsenal against superbugs. However, both compounds still require refinement and clinical trials before they can be prescribed to humans.
A New Hope for the Global Health Crisis
With the growing threat of antibiotic resistance, this discovery is a breath of fresh air for the medical world. If clinical trials succeed, these new antibiotics could be used longer before bacteria become resistant again, reducing the risk of severe infections. Researchers are optimistic that AI will become a key tool in future drug research, combining advanced technology with medical science to address global health challenges.
Conclusion:
The discovery of two new antibiotics by MIT’s AI demonstrates that artificial intelligence is not just an assisting tool but an innovator in medical research. The speed and efficiency of AI in creating new drugs provide real hope in tackling the escalating global antibiotic resistance crisis.
Read More: Telkom Launches OCA AI Platform as a New Solution